1907 (1907) Fair Value & Analysis

Basic Materials · Market cap HK$8.3B

1 1907 1907 · HK

PriceHK$1.96

Fair ValueHK$0.4100

Upside-79.1%

Quality41/100

Watch 1907 for free — get notified when fair value or trend changes. Watch for free

Evidence: Medium Range HK$0.2000 – HK$0.5600

Fair value as of: Jul 2, 2026

From 25 valuation models · updated today

Share price −24.8% over the past month.

Price vs Fair Value (12 months)

12‑month range HK$1.92 – HK$3.87 · fair‑value band HK$0.2000 – HK$0.5600 · the HK$1.96 price screens above the HK$0.4100 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

1907 (1907) currently trades at HK$1.96, while our model-based Fair Value estimate is HK$0.4100 — implying the stock looks roughly 79.1% overvalued today. We read business quality at 41/100 (below-average quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

Over the trailing twelve months, 1907 generated revenue of HK$39.3B at a net margin of 0.2%. Revenue declined 16.1% year over year. It earns a return on equity of 0.9%. Net debt stands at HK$32.5B. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$39.3B

Revenue growth (YoY) -16.1%

Net margin 0.2%

Return on equity 0.9%

Free cash flow HK$622M FY2025

P/E ratio 196.0

More key figures

Operating margin 1.9%

EPS (TTM) HK$0.0100

Dividend yield 0.2%

EPS growth (YoY) -74.0%

Net debt HK$32.5B FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

1907 reported revenue of HK$39.3B in FY2025 versus HK$39.4B in FY2021, a compound −0.1%/yr. Reported net income was HK$58.0M in FY2025, compounding −61.4%/yr from FY2021.

Revenue −0.1%/yr

FY21 HK$39.4B

FY22 HK$43.1B

FY23 HK$46.1B

FY24 HK$47.5B

FY25 HK$39.3B

Net income −61.4%/yr

FY21 HK$2.6B

FY22 HK$1.9B

FY23 HK$861M

FY24 HK$20.1M

FY25 HK$58.0M

Is 1907 fairly valued? → Check now

Similar stocks

6 more Chemicals stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock	Price	Fair Value	vs Fair Value
Linde plc LIN	€443.00	€109.98	-75%
Shin-Etsu Chemical Co SHECY	$22.77	$13.22	-42%
BASF SE BAS	€49.17	€23.76	-52%
Ningxia Baofeng Energy Group 600989	¥22.46	¥37.07	+65%
Dow Inc D1OW34	R$43.92	R$86.14	+96%
Ganfeng Lithium Group 002460	¥72.05	¥21.69	-70%

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 1907 (1907) undervalued?

As of Jul 2, 2026, our model estimates a fair value of HK$0.4100 versus a price of HK$1.96 — about −79% (overvalued). Model-based estimate, not financial advice.

What is the fair value of 1907?

Our model-based fair value for 1907 is HK$0.4100 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$1.96.

What is the quality score of 1907?

1907 has a Quality Score of 41/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 1907 (1907)?

1907 reported trailing-twelve-month revenue of about HK$39.3B (latest available figure, as of Jul 2, 2026).

What is the net profit margin of 1907?

The net profit margin of 1907 is about 0.2%, meaning it keeps roughly 0.2% of revenue as net income. Based on the latest reported figures.

Does 1907 pay a dividend?

1907 currently shows a dividend yield of about 0.21% relative to its recent price (as of Jul 2, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.